Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (DRKS00041150) titled 'Prospective Multicentre Evaluation of an AI-Based Prostate MRI Analysis Tool for the Detection of Clinically Significant Prostate Cancer Using Histopathology as Reference Standard' on July 29.
Study Type: interventional
Study Design:
Allocation: N/A: single arm study
Masking: Open (masking not used)
Control: uncontrolled
Assignment: single
Study design purpose: diagnostic
Primary Sponsor: Universitatsklinikum Dusseldorf
Condition:
C61
Malignant neoplasm of prostate
Intervention:
Group 1: Patients with suspected prostate cancer will be recruited during routine clinical care at the participating urology departmen...